• Home
  • GROUP HOME
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • R&D
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Firalis
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Products
    • MEMORYLINC
    • NEUROLINCS
    • FIMICS
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
  • R&D
  • Quality
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
contact
RNAs to predict COVID-19's cardiovascular outcomes

RNAs to predict COVID-19's cardiovascular outcomes

Check out the video presentation of our COVIRNA project, in which, 15 European partners from healthcare, academia and industry, collaborate around the objective of generating an innovative diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications in the context of the current pandemic, in order to improve their surveillance and care.

 

https://www.youtube.com/watch?v=-dFSqFm1mUU&t=2s

 

The COVIRNA project is based on FIRALIS’ innovative “FIMICS panel” (click to know more on FIMICS) of cardiac enriched long non-coding RNAs (“lncRNA”s) and coordinated by the Luxembourg Institute of Health (“LIH”). For more information on COVIRNA project, check our press release here and the consortium website here : https://covirna.eu/

19.07.2021

Follow us on LinkedIn
The embedded code will become available once you have connected a domain to your website.
OK